Centrient Pharmaceuticals Netherlands

Company Overview

Centrient Pharmaceuticals is a global leader in sustainable, enzymatic antibiotics, next generation statins, and anti-fungals. For over 150 years, we have been at the forefront of modern healthcare, producing and selling intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules, and other finished dosage forms (FDFs). Our commitment to Quality, Reliability, and Sustainability drives everything we do, and our team of over 1,800 employees work tirelessly to meet the needs of our customers.

At Centrient Pharmaceuticals, we are dedicated to creating a sustainable future for healthcare. We actively participate in the fight against antimicrobial resistance, recognizing the importance of responsible antibiotic use. This commitment to sustainability is ingrained in our company culture and is reflected in our operations and products.

Founded as the ‘Nederlandsche Gist- en Spiritusfabriek’ in the Netherlands, our company has evolved over the years and was previously known as Gist Brocades and DSM Sinochem Pharmaceuticals. Today, our headquarters are located in Rotterdam, and we have production facilities and sales offices in key locations such as China, India, Spain, and the United States. This global presence allows us to effectively serve our customers and meet the growing demand for our high-quality products.

Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm. This partnership has enabled us to continue our legacy of innovation and growth, while also expanding our reach and impact in the pharmaceutical industry.

We are proud to be at the forefront of modern healthcare, providing essential and life-saving medicines to people all over the world. With our focus on sustainability, we are shaping the future of healthcare and making a positive impact on the world. At Centrient Pharmaceuticals, we are committed to building a better, healthier world for generations to come.